PharmaEngine (4162) — Financial Flexibility Index
PharmaEngine (4162) has a Financial Flexibility Index of 0.47x as of September 2025. Free cash flow of NT$53.12 Million (operating CF NT$53.01 Million minus capex NT$115.00K) represents 0% of total liabilities (NT$112.86 Million). Also explore net asset growth rate of PharmaEngine to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
PharmaEngine Financial Flexibility Index (2009–2024)
Historical Financial Flexibility Index trend for PharmaEngine across 16 annual periods. Check PharmaEngine (4162) strategic investment index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for PharmaEngine (2009–2024)
Year-by-year free cash flow to debt coverage for PharmaEngine. For the full company profile including market capitalisation, see PharmaEngine stock valuation.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.02x | NT$458.15 Million | NT$456.73 Million | NT$448.01 Million | ▼ -63.9% |
| 2023 | 2.83x | NT$257.93 Million | NT$256.97 Million | NT$91.01 Million | ▲ +30.0% |
| 2022 | 2.18x | NT$205.96 Million | NT$202.01 Million | NT$94.47 Million | ▼ -79.4% |
| 2021 | 10.60x | NT$929.90 Million | NT$929.67 Million | NT$87.70 Million | ▲ +3075.0% |
| 2020 | 0.33x | NT$65.38 Million | NT$64.77 Million | NT$195.78 Million | ▲ +228.9% |
| 2019 | 0.10x | NT$16.29 Million | NT$16.08 Million | NT$160.40 Million | ▼ -97.9% |
| 2018 | 4.88x | NT$745.74 Million | NT$745.23 Million | NT$152.67 Million | ▲ +388.2% |
| 2017 | -1.69x | NT$-338.81 Million | NT$-339.30 Million | NT$199.90 Million | ▼ -131.2% |
| 2016 | 5.43x | NT$871.53 Million | NT$870.38 Million | NT$160.48 Million | ▼ -6.2% |
| 2015 | 5.79x | NT$459.80 Million | NT$447.99 Million | NT$79.41 Million | ▼ -20.5% |
| 2014 | 7.28x | NT$131.18 Million | NT$131.09 Million | NT$18.02 Million | ▲ +498.1% |
| 2013 | -1.83x | NT$-47.37 Million | NT$-47.37 Million | NT$25.90 Million | ▼ -137.8% |
| 2012 | 4.84x | NT$68.73 Million | NT$68.64 Million | NT$14.20 Million | ▼ -72.7% |
| 2011 | 17.72x | NT$276.29 Million | NT$275.49 Million | NT$15.59 Million | ▲ +530.9% |
| 2010 | -4.11x | NT$-56.95 Million | NT$-57.26 Million | NT$13.85 Million | ▼ -38.9% |
| 2009 | -2.96x | NT$-90.33 Million | NT$-90.54 Million | NT$30.50 Million | — |